Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
NCCN Guidelines® Insights: Survivorship, Version 3.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 17, 2026
Low-fat dietary pattern and dietary advanced glycation end-products intake: a secondary analysis of the Women's Health Initiative randomized trial.
Journal: British journal of cancer
Published: December 17, 2025
Replication of Sensor-Based Categorization of Upper-Limb Performance in Daily Life in People Post Stroke and Generalizability to Other Populations.
Journal: Sensors (Basel, Switzerland)
Published: June 14, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2025
A qualitative exploration of patient and clinician needs and preferences for a physical activity intervention during breast cancer chemotherapy.
Journal: BMC cancer
Published: February 28, 2025
Route and efficiency analysis of cancer health care (REACH): Investigating sociodemographic and rurality of metastatic breast cancer patients at an NCI-designated facility.
Journal: The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association
Published: January 23, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: December 17, 2024
Returning to work after breast cancer: a longitudinal analysis of employment and financial hardship.
Returning to work after breast cancer: a longitudinal analysis of employment and financial hardship.
Journal: Breast cancer research and treatment
Published: December 09, 2024
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 21, 2024
An Internet Mantram Repetition Program to Promote Well-being in Breast Cancer Survivors: A Feasibility Randomized Controlled Trial.
Journal: Integrative cancer therapies
Published: October 20, 2024
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Journal: Nature communications
Published: October 17, 2024
Last Updated: 09/26/2026